Grants.govALN 93.103RFA-FD-27-001
Research on Complex Generics
Food and Drug Administration
$0–$2.5MCloses in 30 days· Dec 14, 2026
Summary
The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.
Related documents
Geography
US
Award range
$0–$2.5M
Cost share
Not required
Open date
Nov 13, 2026
Close date
Dec 14, 2026
Funding type
Cooperative agreement
Expected awards
1
Opportunity type
Discretionary
Source
Grants.gov
Eligibility
Institution
Only the following applicant is eligible to apply for this single source funding: The University of Maryland | applicant types: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Categories
HealthAgricultureArts Culture